Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation Division.
Urogynaecology research team recruit first UK patient to first line treatment for stress urinary incontinence study
Urogynaecology research team at St Mary’s, have recruited the first patient in the UK to an observational study investigating the effectiveness of a urethral bulking procedure in women
Congratulations to Professor Graeme Black, Honorary Consultant in Genetics and Ophthalmology, for his OBE in the Queen’s Birthday Honours List
Professor Graeme Black, Honorary Consultant and Professor in Genetics and Ophthalmology has been awarded the Order of the British Empire in the Queen’s Birthday Honours List.
NIHR Manchester Clinical Research Facility receives glowing report on placement from student nurse
Enhancements to the student nurse placement programme at the Children’s Clinical Research Facility at CMFT have been reflected in their recent student evaluations.
Manchester Heart Centre leading national patient recruitment in national study
Congratulations to Manchester Heart Centre research staff for leading the way nationally for patient recruitment, by becoming the top recruiting site on the PRE18FFIR in the country for a second time.
Around 120 delegates celebrate the launch of the NIHR Manchester BRC and CRF
The event provided an overview of the research plans supported by the NIHR’s £41m BRC/CRF investment (2017–2022), in the context of the wider Greater Manchester Health and Social Care Partnership.
New test for childhood genetic disorders ‘transformational’
Diagnoses of a group of rare genetic disorders in children could be transformed by a new test developed by University of Manchester researchers.
GM AHSN Innovation Funds
The GM AHSN has developed a suite of Innovation Funds to support and stimulate the development of innovative technologies.
Orphan drug designation for gene therapy treatment of rare genetic disease
Orchard Therapeutics Ltd. Receives Orphan Drug Designation for OTL-201, ex-vivo lentiviral gene therapy treatment for Mucopolysaccharidosis type IIIA